Post-Trade Analysis: Summit Therapeutics Inc (SMMT) Slides -5.04, Closing at 7.72

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $8.13 in the prior trading day, Summit Therapeutics Inc (NASDAQ: SMMT) closed at $7.72, down -5.04%. In other words, the price has decreased by -$5.04 from its previous closing price. On the day, 3.03 million shares were traded. SMMT stock price reached its highest trading level at $8.475 during the session, while it also had its lowest trading level at $7.615.


Our goal is to gain a better understanding of SMMT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.97 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 2.48 whereas as Long-Term Debt/Eq ratio is at 2.39.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May 07, 2024, initiated with a Buy rating and assigned the stock a target price of $7.

On March 26, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $8.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.

Zanganeh Mahkam bought 26,000 shares of SMMT for $96,720 on Mar 27 ’24. The Chief Executive Officer now owns 520,814 shares after completing the transaction at $3.72 per share. On Mar 26 ’24, another insider, Dhingra Ankur, who serves as the Chief Financial Officer of the company, bought 100,000 shares for $3.75 each. As a result, the insider paid 375,000 and bolstered with 354,958 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 5419285504 and an Enterprise Value of 5372124672.

Stock Price History:

Over the past 52 weeks, SMMT has reached a high of $11.25, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is 68.46%, while the 200-Day Moving Average is calculated to be 140.17%.

Shares Statistics:

The stock has traded on average 4.03M shares per day over the past 3-months and 13950170 shares per day over the last 10 days, according to various share statistics. A total of 701.66M shares are outstanding, with a floating share count of 82.98M. Insiders hold about 88.18% of the company’s shares, while institutions hold 7.12% stake in the company. Shares short for SMMT as of 1715731200 were 22565474 with a Short Ratio of 5.60, compared to 1713139200 on 22896771. Therefore, it implies a Short% of Shares Outstanding of 22565474 and a Short% of Float of 27.08.

Most Popular